COMBRETASTATIN ANALOGS FOR USE IN THE TREATMENT OF CANCER
The present invention relates to specific analogs of combretastatin, in particular the compounds of formula (I) as described and defined herein, and pharmaceutical compositions comprising the compounds, as well as their medical use, in particular in the treatment or prevention of cancer, including multidrug-resistant cancer.
-
(2011/11/30)
More Articles about upstream products of 1345962-05-1